L-oxiracetam improved a cognitive test score after traumatic brain injury
A randomized trial found greater cognitive test improvement with L-oxiracetam than placebo or oxiracetam, but no detected difference between the active drugs on secondary efficacy outcomes.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
L-oxiracetam produced larger gains on the main cognitive test than placebo and oxiracetam in adults with traumatic brain injury. Other efficacy measures, which included daily activities, showed no detected difference between the active drugs. These findings concern recovery after brain injury and do not establish cognitive benefits for healthy people.
This brief uses only the abstract, which notes loss to follow-up. It does not establish whether the cognitive-score difference meant a meaningful daily-life improvement or persisted beyond the reported assessment.
What researchers found
LOTCA cognitive score change
Least-squares mean difference in change from baseline to 90 days post treatment: L-oxiracetam versus placebo.
What the main outcome captures
The main outcome was change on the Loewenstein Occupational Therapy Cognitive Assessment, or LOTCA. The estimate describes a difference in cognitive test-score improvement between treatment groups; it is not a percentage improvement in cognition.
Safety within the trial
The trial detected no difference in serious adverse-event proportions among the groups. That result should be read alongside losses to follow-up and does not prove that the treatments have identical safety profiles.
The original publication
Efficacy and safety of L-oxiracetam on cognitive function in patients with traumatic brain injury: a multicentre, randomised, double-blind, phase 3 clinical trial.
Liu T, Wang J, Zhao Z et al.
Signal Transduct Target Ther · 2025
- PubMed ID
- 41381424
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.